Home » Topics » BioWorld Science

BioWorld Science
RSS

Biohaven presents focused analysis data from phase II/III study of troriluzole in AD

Jan. 19, 2021

Grifols to begin clinical evaluation of new COVID-19 treatment

Jan. 19, 2021

BET inhibitors synergize with BCL-2 or HDAC inhibitors in Waldenstrom macroglobulinemia

Jan. 19, 2021

Phase II data reported for cabozantinib in type I neurofibromatosis with PNs

Jan. 19, 2021

EdiGene obtains IND approval in China for ET-01 for transfusion dependent beta-thalassemia

Jan. 18, 2021

Novel anti-mesothelin and anti-FucGM1 ADCs show promising antitumor activity in vivo

Jan. 18, 2021

SinoMab initiates phase I trial in China with SN-1011 for autoimmune disease

Jan. 18, 2021

FDA approves Darzalex Faspro for newly diagnosed light-chain amyloidosis

Jan. 18, 2021

Dosing begins in phase IIa study of STP-705 for cutaneous basal cell carcinoma

Jan. 18, 2021

Nanjing Sanhome Pharmaceutical patents PRMT5 inhibitors

Jan. 18, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...